510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

I.V. Sets Walrus Brand Various Configur-

K830755510(k) TraditionalCleared Apr 28, 198349-day reviewClass II21 CFR 880.5440Recalls 22

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Parameters, Inc. · FPA Set, Administration, Intravascular

Cleared on Apr 28, 1983 after a 49-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled 22 times.

Decided
Apr 28, 1983
Review
49 days
Class
Class II
Product code
FPA
Recalls
22
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K830755Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 7, 2018Class IIZ-0097-2019Nonconforming Material/ComponentBayer has received reports of loose particulate in the filter when the dust cap is removed. Bayer conducted further testing confirming the dust cap may generate particulate which may potentially enter the fluid path.
Feb 1, 2010Not classifiedZ-1128-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1115-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1119-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1121-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1120-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1112-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1130-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1124-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1116-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1123-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1125-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1113-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1126-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1129-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1127-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1117-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1114-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1118-2010Component design/selectionSterility may be compromised.
Feb 1, 2010Not classifiedZ-1122-2010Component design/selectionSterility may be compromised.
Feb 11, 2009Not classifiedZ-1489-2009Device DesignLeakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.
Feb 11, 2009Not classifiedZ-1490-2009Device DesignLeakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.

The 5 latest of 22 recalls; the web page lists all.

No ancestor or descendant has a Class I recall.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

More from Medical Parameters, Inc.

6 FDA decisions under this applicant name. See the company

  • K862190Walrus: Double Balloon Shunting CatheterMedical Parameters, Inc. · 1986
  • K844444Esophageal StethoscopeMedical Parameters, Inc. · 1985
  • K833825Multi-Lumen Intravenous Infusion CathMedical Parameters, Inc. · 1984
  • K830754Blood Pressure Monitoring Kits,WalrusMedical Parameters, Inc. · 1983
  • K831239Walrus Percutaneous Introducer SetMedical Parameters, Inc. · 1983

Recent decisions in FPA

The FPA category page

  • K260261Gravity Blood Sets with 200µm FilterB.Braun Medical, Inc. · 2026
  • K254123Ecomed Disposable Administration SetsEcomed Solutions, LLC · 2026
  • K261530iiSure Infusion SetDeka Research and Development · 2026
  • K252543AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072, BA-70072-F, BA-70071-DF…Amsino International, Inc. · 2026
  • K251375PuraCath Firefly Needleless Connector IT (9005)Puracath Medical, Inc. · 2026

https://510kreport.com/device/K830755 · printed Nov 3, 2026

Cite this page

510(k) Report. “K830755: I.V. Sets Walrus Brand Various Configur-.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K830755

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026